KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to $18.6 million.

  • Rigel Pharmaceuticals' Prepaid Assets rose 8567.14% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 8567.14%. This contributed to the annual value of $10.2 million for FY2024, which is 6235.43% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Prepaid Assets stood at $18.6 million, which was up 8567.14% from $16.7 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Prepaid Assets high stood at $23.3 million for Q1 2025, and its period low was $3.0 million during Q3 2023.
  • Over the past 5 years, Rigel Pharmaceuticals' median Prepaid Assets value was $8.3 million (recorded in 2022), while the average stood at $9.4 million.
  • In the last 5 years, Rigel Pharmaceuticals' Prepaid Assets plummeted by 5103.13% in 2023 and then skyrocketed by 23147.6% in 2024.
  • Over the past 5 years, Rigel Pharmaceuticals' Prepaid Assets (Quarter) stood at $7.4 million in 2021, then rose by 11.43% to $8.3 million in 2022, then decreased by 24.19% to $6.3 million in 2023, then surged by 62.35% to $10.2 million in 2024, then surged by 82.55% to $18.6 million in 2025.
  • Its last three reported values are $18.6 million in Q3 2025, $16.7 million for Q2 2025, and $23.3 million during Q1 2025.